What’s the hottest biotech R&D field in venture investing?
If you guessed cancer without even thinking about it, you get a gold Endpoints star. But just how much hotter is oncology compared to every other field in biopharma R&D?
“Oncology grabs the largest percentage of venture-backed exits versus any other indication in biopharma, both in number of deals and in deal value,” notes Jonathan Norris, the managing director of Silicon Valley Bank’s healthcare practice.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.